Literature DB >> 14714130

Cyclin D1 expression does not effect cell proliferation in adenoid cystic carcinoma of the salivary gland.

Ryuji Yasumatsu1, Yuichiro Kuratomi, Torahiko Nakashima, Muneyuki Masuda, Tomoya Yamamoto.   

Abstract

Adenoid cystic carcinoma is a malignant tumor of salivary gland origin. It tends to grow slowly, but shows frequent recurrence and metastasis. Cyclin D1, a cell-cycle regulation protein, has been reported to be overexpressed in various types of cancer and to correlate with poor survival of the patients. However, the prognostic significance of cyclin D1 expression in ACC of the salivary glands has not yet been determined. To evaluate the role of cyclin D1 in the biological regulation of ACC, we constitutively expressed an antisense cyclin D1 complementary DNA (cDNA) in an established ACC cell line that exhibits high endogenous expression of cyclin D1. The effect of cyclin D1 expression on in vitro cell growth and cell cycle were examined. In addition, we also examined the immunohistochemical expression of cyclin D1 protein in 31 cases of ACC of the salivary gland and correlated its expression with proliferative activity or prognosis. There were no significant differences of the in vitro growth and in the percentage of the total cell population in the G1 phase and S phase between antisense cyclin D1 clones and control clones. Thirty-two percent of tumors derived from surgical specimens examined were immunohistochemically positive for cyclin D1 protein. No association was found between cyclin D1 expression and cell proliferation or the clinical outcome of the patients. It is concluded that cyclin D1 overexpression alone does not induce a marked increase in the proliferative activity of ACC cells and that expression of this protein is not linked to poor prognosis in adenoid cystic carcinoma of the salivary gland.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14714130     DOI: 10.1007/s00405-003-0724-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  25 in total

1.  Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer.

Authors:  A Itami; Y Shimada; G Watanabe; M Imamura
Journal:  Oncology       Date:  1999-11       Impact factor: 2.935

Review 2.  Cyclins and oncogenesis.

Authors:  T Motokura; A Arnold
Journal:  Biochim Biophys Acta       Date:  1993-05-25

Review 3.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

4.  Prognostic factors for adenoid cystic carcinoma of the head and neck: a retrospective evaluation of 96 cases.

Authors:  K Hamper; F Lazar; M Dietel; J Caselitz; J Berger; H Arps; U Falkmer; G Auer; G Seifert
Journal:  J Oral Pathol Med       Date:  1990-03       Impact factor: 4.253

5.  Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma.

Authors:  A K el-Naggar; K Steck; J G Batsakis
Journal:  Cytometry       Date:  1995-09-01

6.  Clinical relevance of Ki-67 expression in bone tumors.

Authors:  K Scotlandi; M Serra; M C Manara; D Maurici; S Benini; G Nini; M Campanacci; N Baldini
Journal:  Cancer       Date:  1995-02-01       Impact factor: 6.860

7.  Cyclin D1 and prognosis in human breast cancer.

Authors:  C Gillett; P Smith; W Gregory; M Richards; R Millis; G Peters; D Barnes
Journal:  Int J Cancer       Date:  1996-04-22       Impact factor: 7.396

8.  Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.

Authors:  W Jiang; S M Kahn; P Zhou; Y J Zhang; A M Cacace; A S Infante; S Doi; R M Santella; I B Weinstein
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

9.  Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.

Authors:  M H Bennett; G D Wilson; S Dische; M I Saunders; C A Martindale; B M Robinson; A E O'Halloran; M D Leslie; J H Laing
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

10.  Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.

Authors:  G Forster; T G Cooke; L D Cooke; P D Stanton; G Bowie; P M Stell
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

View more
  4 in total

1.  Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.

Authors:  Ana Amélia de Souza; Albina Altemani; Fabricio Passador-Santos; Cecilia Pedroso Turssi; Ney Soares de Araujo; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Virchows Arch       Date:  2015-07-09       Impact factor: 4.064

2.  The prognostic significance of β-catenin, cyclin D1 and PIN1 in minor salivary gland carcinoma: β-catenin predicts overall survival.

Authors:  Sven Schneider; Dietmar Thurnher; Rudolf Seemann; Markus Brunner; Lorenz Kadletz; Bahil Ghanim; Klaus Aumayr; Gregor Heiduschka; Claudia Lill
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-24       Impact factor: 2.503

3.  Abnormal activation of the Akt signaling pathway in adenoid cystic carcinoma.

Authors:  Karla Flaviana Carneiro Castelo Branco; Andre Luis Ribeiro Ribeiro; Raíssa Pinheiro de Mendonça; João de Jesus Viana Pinheiro; Maria Sueli da Silva Kataoka; Maria Vanda Catão Arnaud; Sérgio de Melo Alves Junior
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-26       Impact factor: 2.503

4.  Assessment of p16 expression and HPV infection in adenoid cystic carcinoma of the lacrimal gland.

Authors:  Yuchuan Wang; Yuan Tian; Jinyong Lin; Luxia Chen; Liming Wang; Peng Hao; Ruifang Han; Ming Ying; Xuan Li; Xin Tang
Journal:  Mol Vis       Date:  2018-02-06       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.